Tiziana Life Sciences PLC(TLSA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TLSA Tiziana Life Sciences PLC

Not Yet Opened 12-20 16:00:00 EST

0.7750

-0.0570

-6.85%

盘后0.7750

+0.00000.00%

19:52 EST

High0.8310	Low0.7380	Vol568.12K
Open0.8000	D1 Closing0.8320	Amplitude11.18%
Mkt Cap84.54M	Tradable Cap54.05M	Total Shares109.09M
T/O437.64K	T/O Rate0.81%	Tradable Shares69.74M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"TLSA","market":"US","secType":"STK","nameCN":"Tiziana Life Sciences PLC","latestPrice":0.775,"timestamp":1734728400000,"preClose":0.832,"halted":0,"volume":568118,"hourTrading":{"tag":"盘后","latestPrice":0.775,"preClose":0.775,"latestTime":"19:52 EST","volume":194,"amount":149.7139,"timestamp":1734742327614},"delay":0,"floatShares":69737013,"shares":109085902,"eps":-0.133432,"marketStatus":"Not Yet Opened","change":-0.057,"latestTime":"12-20 16:00:00 EST","open":0.8,"high":0.831,"low":0.738,"amount":437639.83309,"amplitude":0.111779,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.133432,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734944400000},"marketStatusCode":0,"adr":0,"adrRate":2,"listingDate":1542690000000,"exchange":"NASDAQ","adjPreClose":0.832,"preHourTrading":{"tag":"盘前","latestPrice":0.87,"preClose":0.832,"latestTime":"09:23 EST","volume":3268,"amount":2681.059782,"timestamp":1734704632008},"postHourTrading":{"tag":"盘后","latestPrice":0.775,"preClose":0.775,"latestTime":"19:52 EST","volume":194,"amount":149.7139,"timestamp":1734742327614},"volumeRatio":1.028887677592384,"impliedVol":0.133,"impliedVolPercentile":0.004},"requestUrl":"/m/hq/s/TLSA","defaultTab":"news","newsList":[{"id":"2492642956","title":"Tiziana Life Sciences announces first patient dosed with intranasal foralumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2492642956","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492642956?lang=en_us&edition=fundamental","pubTime":"2024-12-17 20:10","pubTimestamp":1734437436,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences (TLSA) announced a significant milestone in its clinical development program for Alzheimer’s disease. The Company has success...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tiziana-life-sciences-announces-first-patient-dosed-with-intranasal-foralumab?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tiziana-life-sciences-announces-first-patient-dosed-with-intranasal-foralumab?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSA","BK4139"],"gpt_icon":0},{"id":"2492495595","title":"Tiziana Life Sciences Announces First Patient With Moderate Alzheimer’s Disease Dosed With Intranasal Foralumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2492495595","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492495595?lang=en_us&edition=fundamental","pubTime":"2024-12-17 20:00","pubTimestamp":1734436802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUA5NKBFT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"gpt_icon":0},{"id":"2489454766","title":"3 US Penny Stocks With Market Caps Under $200M To Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2489454766","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489454766?lang=en_us&edition=fundamental","pubTime":"2024-12-05 21:08","pubTimestamp":1733404128,"startTime":"0","endTime":"0","summary":"As the Dow, S&P 500, and Nasdaq reach record highs fueled by a surge in technology stocks, investor optimism is palpable. In such a buoyant market climate, penny stocks—often overlooked yet still significant—present intriguing opportunities for those seeking growth potential in smaller or newer companies. Though the term may seem outdated, these stocks can offer substantial returns when backed by solid financials and strategic positioning.Underneath we present a selection of stocks filtered out by our screen.Overview: Tiziana Life Sciences Ltd is a biotechnology company that focuses on discovering and developing molecules to treat human diseases in oncology and immunology in the United States, with a market cap of $99.27 million.Overview: Quantum-Si is a life sciences company focused on developing a single-molecule detection platform for Next Generation Protein Sequencing, with a market cap of approximately $159.84 million.Operations: The company generates its revenue from the Biotechn","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-us-penny-stocks-market-130848709.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BABB","BK4121","BK4563","PVL","BK4209","BK4075","QSIAW","BK4213","BK4551","BK4141","RLX","SQNS","BK4526","TLSA","QSI"],"gpt_icon":0},{"id":"2488160225","title":"Tiziana Life Sciences Expands MS Clinical Trial Network","url":"https://stock-news.laohu8.com/highlight/detail?id=2488160225","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488160225?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:29","pubTimestamp":1733315344,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences (TLSA) has released an update. Tiziana Life Sciences is expanding its Phase 2 trial for intranasal foralumab, a novel treatme...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-expands-ms-clinical-trial-network?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-expands-ms-clinical-trial-network?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0106831901.USD","IE00BZ1G4Q59.USD","LU0158827948.USD","LU1720051017.SGD","BK4585","LU2271345857.HKD","LU2089284900.SGD","LU0971096721.USD","LU1668664300.SGD","LU1989772923.USD","LU1074936037.SGD","BK4588","LU1363072403.SGD","LU1162221912.USD","LU2357305700.SGD","LU0098860793.USD","LU0314104364.USD","BK4581","LU0158827781.USD","BK4516","BK4139","LU1989772840.SGD","LU0106261372.USD","LU0006306889.USD","BK4127","LU2023251221.USD","LU2028103732.USD","LU0225283273.USD","LU2089283258.USD","LU1720051108.HKD","TLSA","LU0320765646.SGD","LU2111349929.HKD","IE00BKVL7J92.USD","LU0267386448.USD","BK4534","LU1548497426.USD","BK4504"],"gpt_icon":0},{"id":"2488167618","title":"Tiziana Life Sciences expands Phase 2 trial for non-active SPMS","url":"https://stock-news.laohu8.com/highlight/detail?id=2488167618","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488167618?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:07","pubTimestamp":1733314032,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences (TLSA) announced the expansion of its Phase 2 clinical trial evaluating intranasal foralumab for non-active secondary progres...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tiziana-life-sciences-expands-phase-2-trial-for-non-active-spms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tiziana-life-sciences-expands-phase-2-trial-for-non-active-spms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLSA"],"gpt_icon":0},{"id":"2488416239","title":"Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers","url":"https://stock-news.laohu8.com/highlight/detail?id=2488416239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488416239?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:00","pubTimestamp":1733313602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nTUA2SQWYD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"gpt_icon":0},{"id":"2484894227","title":"Tiziana Life Sciences Says Grant Application Approved by ALS Association","url":"https://stock-news.laohu8.com/highlight/detail?id=2484894227","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484894227?lang=en_us&edition=fundamental","pubTime":"2024-11-19 22:00","pubTimestamp":1732024833,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences  said Tuesday the ALS Association has approved its grant application for funding a 20-participant clinical study of two doses of its intranasal foralumab candidate to treat amyotrophic lateral sclerosis.The company said it will receive the funding as part of the Hoffman ALS Clinical Trial Awards Program.Terms of the funding weren't disclosed.Tiziana said it is also evaluating intranasal foralumab in a phase 2a multicenter, dose-ranging study in patients with non-active secondary progressive multiple sclerosis.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TLSA"],"gpt_icon":0},{"id":"2484943192","title":"Tiziana Life Sciences Secures ALS Trial Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2484943192","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484943192?lang=en_us&edition=fundamental","pubTime":"2024-11-19 20:28","pubTimestamp":1732019308,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences (TLSA) has released an update. Tiziana Life Sciences has secured funding from the ALS Association to conduct a 20-patient cli...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-secures-als-trial-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-secures-als-trial-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSA","BK4139"],"gpt_icon":0},{"id":"2482178295","title":"Donald Trump Gives Tesla Wings For 27% Rally Since Presidential Election","url":"https://stock-news.laohu8.com/highlight/detail?id=2482178295","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482178295?lang=en_us&edition=fundamental","pubTime":"2024-11-11 20:50","pubTimestamp":1731329405,"startTime":"0","endTime":"0","summary":"The EV giant received a substantial price target hike Monday, suggesting 24% upside.","market":"sg","thumbnail":"https://www.investors.com/wp-content/uploads/2024/10/Stock-TelsaMusksmile-05-shutt-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2024/10/Stock-TelsaMusksmile-05-shutt-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investors.com/news/tesla-stock-donald-trump-election-rally/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["BK4581","BK4516","IE00BSNM7G36.USD","LU2602419157.SGD","LU1861558580.USD","BK4551","LU0097036916.USD","LU0820561818.USD","LU1551013342.USD","ARKW","LU0943347566.SGD","LU1861559042.SGD","LU2023250330.USD","IE00B1XK9C88.USD","LU0234572021.USD","BK4544","BK4592","LU2249611893.SGD","TLSA","BK4550","TSLA","BK4534","LU0056508442.USD","BK4555","BK4574","LU1720051017.SGD","LU2326559502.SGD","BK4585","SG9999015945.SGD","LU2087621335.USD","LU2063271972.USD","LU0823414478.USD","LU1852331112.SGD","LU0689472784.USD","LU1720051108.HKD","LU0348723411.USD","LU1914381329.SGD","LU2756315664.SGD","LU1435385759.SGD","ARKQ","TSLL","LU0719512351.SGD","LU0234570918.USD","SG9999015986.USD","LU2213496289.HKD","LU0820562030.AUD","LU1429558221.USD","ARKK","LU1145028129.USD","LU0198837287.USD"],"gpt_icon":1},{"id":"2482248415","title":"Tesla Reclaims $1 Trillion Market Cap For First Time Since 2022 In Huge Trump Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2482248415","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482248415?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:12","pubTimestamp":1731082359,"startTime":"0","endTime":"0","summary":"Tesla stock soared Friday, back above a $1 trillion market cap. The EV giant is on pace for its best weekly performance since January 2023, fueled by Donald Trump's victory.","market":"us","thumbnail":"https://www.investors.com/wp-content/uploads/2024/02/Stock-Tesla-2024-model3-04-company-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2024/02/Stock-Tesla-2024-model3-04-company-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investors.com/news/tesla-stock-1-trillion-market-cap-for-first-time-since-2022/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["BK4139","LU0053666078.USD","BK4555","IE00BJLML261.HKD","LU2756315664.SGD","BK4551","LU2357305700.SGD","BK4548","LU1551013342.USD","LU1861220033.SGD","LU2602419157.SGD","LU2213496289.HKD","LU1861558580.USD","LU0820561909.HKD","LU0056508442.USD","ARKQ","TLSA","LU1720051017.SGD","LU1551013425.SGD","LU0097036916.USD","LU0964807845.USD","LU0234570918.USD","LU1914381329.SGD","SG9999015945.SGD","IE00B1XK9C88.USD","BK4592","LU2087621335.USD","SG9999015952.SGD","ARKW","LU0689472784.USD","LU1839511570.USD","LU0820561818.USD","LU0316494557.USD","LU1720051108.HKD","BK4516","SG9999015978.USD","LU2756315318.SGD","IE00BSNM7G36.USD","TSLA","IE00BWXC8680.SGD","LU2063271972.USD","ARKK","LU0466842654.USD","LU0943347566.SGD","LU1629891620.HKD","LU1548497426.USD","LU0348723411.USD","LU0823414478.USD","LU1435385759.SGD","TSLL"],"gpt_icon":1},{"id":"2481763822","title":"Cathie Wood Sells Tesla Before Election; Musk Cabinet Position 'Not What Shareholders Want To See'","url":"https://stock-news.laohu8.com/highlight/detail?id=2481763822","media":"Blockhead","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481763822?lang=en_us&edition=fundamental","pubTime":"2024-11-05 23:03","pubTimestamp":1730818981,"startTime":"0","endTime":"0","summary":"Tesla stock flashed a sell signal Monday and is well below a traditional buy point.","market":"us","thumbnail":"https://www.investors.com/wp-content/uploads/2024/04/Stock-Musk-Trump-shutt-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2024/04/Stock-Musk-Trump-shutt-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investors.com/news/tesla-stock-cathie-wood-elon-musk-election/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU1145028129.USD","BK4139","LU1861558580.USD","LU2357305700.SGD","BK4551","BK4592","LU2023250330.USD","LU1839511570.USD","TSLL","LU0466842654.USD","LU2213496289.HKD","LU2326559502.SGD","SG9999015952.SGD","ARKQ","IE00BWXC8680.SGD","LU0053666078.USD","IE00BSNM7G36.USD","LU0820562030.AUD","LU0316494557.USD","BK4581","LU0943347566.SGD","LU1435385759.SGD","LU1720051108.HKD","BK4588","LU2087621335.USD","BK4550","LU1551013425.SGD","LU2249611893.SGD","LU0198837287.USD","LU0689472784.USD","TLSA","BK4534","SG9999015986.USD","LU2602419157.SGD","LU0234570918.USD","TSLA","LU1629891620.HKD","BK4548","LU0719512351.SGD","SG9999015945.SGD","ARKW","LU0082616367.USD","LU0056508442.USD","LU1551013342.USD","BK4585","LU1548497426.USD","LU2756315664.SGD","ARKK","BK4544","BK4511"],"gpt_icon":1},{"id":"2480308828","title":"Tiziana Life Sciences Highlights Advancements at BIO-Europe 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2480308828","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480308828?lang=en_us&edition=fundamental","pubTime":"2024-11-02 01:27","pubTimestamp":1730482036,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences (TLSA) has released an update. Tiziana Life Sciences is set to showcase its recent clinical advancements, including promising...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-highlights-advancements-at-bio-europe-2024?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-highlights-advancements-at-bio-europe-2024?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","LU1169589451.USD","BK4121","BK4585","TLSA","LU1169590202.USD","BIO"],"gpt_icon":0},{"id":"2480082550","title":"Tiziana Life Sciences Announces $10 Million Share Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2480082550","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480082550?lang=en_us&edition=fundamental","pubTime":"2024-11-01 18:30","pubTimestamp":1730457009,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences (TLSA) has released an update. Tiziana Life Sciences is set to offer up to $10 million in common shares, as confirmed by thei...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-announces-10-million-share-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-announces-10-million-share-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLSA"],"gpt_icon":0},{"id":"2479711866","title":"Tiziana Life Sciences Announces Registered Direct Offering of up to Approximately $10 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2479711866","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479711866?lang=en_us&edition=fundamental","pubTime":"2024-10-31 10:29","pubTimestamp":1730341782,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241031:nTUABX7MY0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"gpt_icon":0},{"id":"2479711376","title":"Tiziana Life Sciences Ltd - Purchase and Sale of 5.3 Mln Common Shares at $0.95 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2479711376","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479711376?lang=en_us&edition=fundamental","pubTime":"2024-10-31 10:29","pubTimestamp":1730341782,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241031:nTUABX7MY0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"gpt_icon":0},{"id":"2479711350","title":"Press Release: Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2479711350","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479711350?lang=en_us&edition=fundamental","pubTime":"2024-10-31 10:29","pubTimestamp":1730341740,"startTime":"0","endTime":"0","summary":"Includes initial funding of approximately $5 million, as well as the option for additional proceeds of approximately $5 million. In addition, the Company has issued the investor an option to acquire up to an additional 5,263,158 common shares at a price of $0.95 per share until the date that is 75 days from the date of the closing of the offering, resulting in additional gross proceeds of up to approximately $5 million, at the election of the investor.This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"gpt_icon":1},{"id":"2479200688","title":"BRIEF-Tiziana Life Sciences Announces Positive Results From Ozempic And Nasal Anti-CD3 Combination Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2479200688","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479200688?lang=en_us&edition=fundamental","pubTime":"2024-10-30 21:14","pubTimestamp":1730294048,"startTime":"0","endTime":"0","summary":"Oct 30  - Novo Nordisk A/S   :   * TIZIANA LIFE SCIENCES ANNOUNCES POSITIVE RESULTS FROM OZEMPIC AND NASAL ANTI-CD3 COMBINATION STUDY   * TIZIANA LIFE SCIENCES LTD - COMBINATION OF NASAL ANTI-CD3 AND SEMAGLUTIDE IMPROVES LIVER HOMEOSTASIS   * TIZIANA LIFE SCIENCES LTD - COMBINATION SIGNIFICANTLY REDUCES INFLAMMATION MARKERS IN OBESITY-RELATED DISORDERSSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSA"],"gpt_icon":0},{"id":"2479201781","title":"Tiziana Life Sciences Announces Positive Results From Ozempic and Nasal Anti-Cd3 Combination Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2479201781","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479201781?lang=en_us&edition=fundamental","pubTime":"2024-10-30 20:30","pubTimestamp":1730291400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nTUA5NJFHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"gpt_icon":0},{"id":"2479201012","title":"Tiziana Life Sciences Ltd - Combination Significantly Reduces Inflammation Markers in Obesity-Related Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2479201012","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479201012?lang=en_us&edition=fundamental","pubTime":"2024-10-30 20:30","pubTimestamp":1730291400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nTUA5NJFHG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"gpt_icon":0},{"id":"2479010702","title":"Tiziana Life Sciences Ltd - Combination of Nasal Anti-Cd3 and Semaglutide Improves Liver Homeostasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2479010702","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479010702?lang=en_us&edition=fundamental","pubTime":"2024-10-30 20:30","pubTimestamp":1730291400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nTUA5NJFHG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tizianalifesciences.com","stockEarnings":[{"period":"1week","weight":-0.1765},{"period":"1month","weight":-0.225},{"period":"3month","weight":-0.2402},{"period":"6month","weight":-0.0313},{"period":"1year","weight":0.2728},{"period":"ytd","weight":0.3839}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-  receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.083199},{"month":2,"riseRate":0,"avgChangeRate":-0.140516},{"month":3,"riseRate":0.5,"avgChangeRate":0.233864},{"month":4,"riseRate":0.5,"avgChangeRate":0.133492},{"month":5,"riseRate":0.5,"avgChangeRate":0.232591},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.027358},{"month":7,"riseRate":0.333333,"avgChangeRate":0.284279},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.121008},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.050999},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.071181},{"month":11,"riseRate":0,"avgChangeRate":-0.138622},{"month":12,"riseRate":0,"avgChangeRate":-0.115187}],"exchange":"NASDAQ","name":"Tiziana Life Sciences PLC","nameEN":"Tiziana Life Sciences PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tiziana Life Sciences PLC(TLSA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tiziana Life Sciences PLC(TLSA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tiziana Life Sciences PLC,TLSA,Tiziana Life Sciences PLC股票,Tiziana Life Sciences PLC股票老虎,Tiziana Life Sciences PLC股票老虎国际,Tiziana Life Sciences PLC行情,Tiziana Life Sciences PLC股票行情,Tiziana Life Sciences PLC股价,Tiziana Life Sciences PLC股市,Tiziana Life Sciences PLC股票价格,Tiziana Life Sciences PLC股票交易,Tiziana Life Sciences PLC股票购买,Tiziana Life Sciences PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tiziana Life Sciences PLC(TLSA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tiziana Life Sciences PLC(TLSA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}